Gary E. Frashier
Director
specialized in biotechnology and emerging pharmaceutical inv
Achillion Pharmaceuticals
Cambodia
Biography
Dr. Fisherman is Managing Director of Synthesis Capital, formerly Advent Healthcare Ventures, a life science venture capital firm, where he specialized in biotechnology and emerging pharmaceutical investments. He has served as a director of Achillion since March 2000 and currently serves on the Audit Committee and the Strategy and Corporate Development Committee.
Research Interest
life sciences
